Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MOREThrough the Community Research Fund Program, the Oligodendroglioma Research Fund supports promising research specifically targeted at creating new treatments for oligodendroglioma and improving patients’ lives.
From 2013 to today, NBTS has funded a total of $2 million in grants to 11 researchers across nine different institutions, all focused on oligodendroglioma and related low-grade glioma research. During this period, NBTS’s strategy to address the problem has focused on funding research projects that revealed genetic risk factors, established models capable of testing potential treatments, built scientific infrastructure to predict if treatments will work, launched novel therapeutic approaches, and helped propel a groundbreaking treatment toward a pivotal clinical trial lead by a biopharma prepared to bring a new therapy to patients.
The latest Oligodendroglioma Research Progress Report focuses specifically on NBTS funded research related to oligodendroglioma. It describes results over a seven-year time span and exciting next steps to drive research forward aimed at novel treatments and ultimately, cures.
To direct your gift to the Oligodendroglioma Research Fund, go to our donation page and select “direct my gift” under the Gift Designation header. The menu will provide an option to support the Oligodendroglioma Research Fund.